MRC/UVRI & LSHTM Uganda Research Unit, Entebbe, Uganda.
London School of Hygiene and Tropical Medicine, London, UK.
AIDS Behav. 2020 Oct;24(10):2872-2884. doi: 10.1007/s10461-020-02838-w.
Many key populations have high-risk behaviors for HIV infection making them suitable for HIV vaccine efficacy trials. However, these behaviors may change when participants enroll into a trial. We used HIV simulated vaccine efficacy trials (SiVETs) nested within observational cohorts of fisherfolks and female sex workers in Uganda to evaluate this difference. We screened observational cohort participants for enrolment into SiVETs, until 572 were enrolled. Those not enrolled (n = 953) continued participation in the observational cohorts. We determined risk behaviors at baseline and at 1 year, assigned a numeric score to each behavior and defined composite score as the sum of reported behaviors. We compared changes in scores over 12 months. Both observational cohorts and SiVETs saw a significant decrease in score but greatest in the SiVETs. Investigators recruiting for trials from these populations should consider the likely effect of reduction in risk behaviors on incident HIV infection and trial statistical power.
许多重点人群存在感染 HIV 的高危行为,使他们适合进行 HIV 疫苗功效试验。然而,当参与者参加试验时,这些行为可能会发生变化。我们使用嵌套在乌干达渔民和性工作者观察队列中的 HIV 模拟疫苗功效试验(SiVET)来评估这种差异。我们对观察队列的参与者进行了 SiVET 登记前的筛选,直到登记了 572 名参与者。未登记的参与者(n=953)继续参加观察队列。我们在基线和 1 年后确定了风险行为,为每个行为分配了一个数值评分,并将综合评分定义为报告行为的总和。我们比较了 12 个月内的评分变化。两个观察队列和 SiVET 都观察到评分显著下降,但 SiVET 下降幅度最大。从这些人群中招募试验的研究人员应考虑风险行为减少对 HIV 感染发生率和试验统计效力的可能影响。